Leukemias: Principles and Practice of Therapy

0 avg rating
( 0 ratings by Goodreads )
 
9781405182355: Leukemias: Principles and Practice of Therapy
View all copies of this ISBN edition:
 
 

Edited by experts from one of the world s largest leukemia centers, this book provides information on the biology of the variety of leukemic disorders, up–to–date diagnostic testing and many new developments in therapy. Chapters covering new treatments present an outlook for the future and explain the rationale for ongoing clinical trials.

Topics include:

  • Targeted therapy, e.g. tyrosine kinase inhibitors (Flt3, Aurora kinase inhibitors, kit inhibitors, BCR–ABL inhibitors)
  • Ras inhibitors
  • Epigenetic therapy (hypomethylaters and histone deacetylase inhibitors)
  • Lenalidomide analogs
  • New chemotherapy drugs, e.g. clofarabine, cloretazine, sapacitabine, forodesine
  • Combinations of chemotherapy with kinase inhibitors (e.g. ALL induction protocols in combination with dasatinib or imatinib)
  • New monoclonal antibodies (lumiliximab, humaxCD20, anti–CD40)
  • Thrombopoietic agents

Leukemias: Principles and Practice of Therapy

  • Includes practical information to guide you in challenging situations, such as treatment of elderly patients, pregnancy, relapsed and refractory disease
  • Incorporates chapters on supportive care and pharmacologic information about the most frequently used drugs in this area

"synopsis" may belong to another edition of this title.

Review:

"This high quality book will be an excellent reference for both fellows and attending physicians who care for patients with leukemic disorders in either a community or academic setting . . . This book is a welcome resource for those entering the field as well as for long–time practitioners who want to stay up to date." (Doody′s, 12 August 2011)

"About this title" may belong to another edition of this title.

Top Search Results from the AbeBooks Marketplace

1.

Published by John Wiley and Sons Ltd, United Kingdom (2010)
ISBN 10: 1405182350 ISBN 13: 9781405182355
New Hardcover First Edition Quantity Available: 1
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description John Wiley and Sons Ltd, United Kingdom, 2010. Hardback. Condition: New. 1. Auflage. Language: English . Brand New Book. Edited by experts from one of the world s largest leukemia centers, this book provides information on the biology of the variety of leukemic disorders, up-to-date diagnostic testing and many new developments in therapy. Chapters covering new treatments present an outlook for the future and explain the rationale for ongoing clinical trials. Topics include: * Targeted therapy, e.g. tyrosine kinase inhibitors (Flt3, Aurora kinase inhibitors, kit inhibitors, BCR-ABL inhibitors) * Ras inhibitors * Epigenetic therapy (hypomethylaters and histone deacetylase inhibitors) * Lenalidomide analogs * New chemotherapy drugs, e.g. clofarabine, cloretazine, sapacitabine, forodesine * Combinations of chemotherapy with kinase inhibitors (e.g. ALL induction protocols in combination with dasatinib or imatinib) * New monoclonal antibodies (lumiliximab, humaxCD20, anti-CD40) * Thrombopoietic agents Leukemias: Principles and Practice of Therapy * Includes practical information to guide you in challenging situations, such as treatment of elderly patients, pregnancy, relapsed and refractory disease * Incorporates chapters on supportive care and pharmacologic information about the most frequently used drugs in this area. Seller Inventory # LIB9781405182355

More information about this seller | Contact this seller

Buy New
96.81
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

2.

Faderl, Stefan
Published by Wileyand#8211;Blackwell (2010)
ISBN 10: 1405182350 ISBN 13: 9781405182355
New Quantity Available: 7
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description Wileyand#8211;Blackwell, 2010. HRD. Condition: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Seller Inventory # FW-9781405182355

More information about this seller | Contact this seller

Buy New
94.02
Convert currency

Add to Basket

Shipping: 9
From United Kingdom to U.S.A.
Destination, rates & speeds

3.

Published by John Wiley and Sons Ltd, United Kingdom (2010)
ISBN 10: 1405182350 ISBN 13: 9781405182355
New Hardcover First Edition Quantity Available: 1
Seller:
Book Depository International
(London, United Kingdom)
Rating
[?]

Book Description John Wiley and Sons Ltd, United Kingdom, 2010. Hardback. Condition: New. 1. Auflage. Language: English. Brand new Book. Edited by experts from one of the world's largest leukemia centers, this book provides information on the biology of the variety of leukemic disorders, up-to-date diagnostic testing and many new developments in therapy. Chapters covering new treatments present an outlook for the future and explain the rationale for ongoing clinical trials. Topics include: * Targeted therapy, e.g. tyrosine kinase inhibitors (Flt3, Aurora kinase inhibitors, kit inhibitors, BCR-ABL inhibitors) * Ras inhibitors * Epigenetic therapy (hypomethylaters and histone deacetylase inhibitors) * Lenalidomide analogs * New chemotherapy drugs, e.g. clofarabine, cloretazine, sapacitabine, forodesine * Combinations of chemotherapy with kinase inhibitors (e.g.ALL induction protocols in combination with dasatinib or imatinib) * New monoclonal antibodies (lumiliximab, humaxCD20, anti-CD40) * Thrombopoietic agents Leukemias: Principles and Practice of Therapy * Includes practical information to guide you in challenging situations, such as treatment of elderly patients, pregnancy, relapsed and refractory disease * Incorporates chapters on supportive care and pharmacologic information about the most frequently used drugs in this area. Seller Inventory # LIB9781405182355

More information about this seller | Contact this seller

Buy New
109.85
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

4.

Published by Wiley-Blackwell (2010)
ISBN 10: 1405182350 ISBN 13: 9781405182355
New Hardcover Quantity Available: 1
Seller:
Irish Booksellers
(Portland, ME, U.S.A.)
Rating
[?]

Book Description Wiley-Blackwell, 2010. Condition: New. book. Seller Inventory # M1405182350

More information about this seller | Contact this seller

Buy New
107.69
Convert currency

Add to Basket

Shipping: 2.50
Within U.S.A.
Destination, rates & speeds

5.

Stefan H. Faderl
Published by John Wiley and Sons Ltd
ISBN 10: 1405182350 ISBN 13: 9781405182355
New Hardcover Quantity Available: 7
Seller:
THE SAINT BOOKSTORE
(Southport, United Kingdom)
Rating
[?]

Book Description John Wiley and Sons Ltd. Hardback. Condition: New. New copy - Usually dispatched within 2 working days. Seller Inventory # B9781405182355

More information about this seller | Contact this seller

Buy New
104.46
Convert currency

Add to Basket

Shipping: 6.94
From United Kingdom to U.S.A.
Destination, rates & speeds

6.

Stefan Faderl (editor), Hagop Kantarjian (editor)
Published by Wiley 2010-11-23, Chichester (2010)
ISBN 10: 1405182350 ISBN 13: 9781405182355
New Hardcover Quantity Available: 1
Seller:
Blackwell's
(Oxford, OX, United Kingdom)
Rating
[?]

Book Description Wiley 2010-11-23, Chichester, 2010. hardback. Condition: New. Seller Inventory # 9781405182355

More information about this seller | Contact this seller

Buy New
103.99
Convert currency

Add to Basket

Shipping: 7.50
From United Kingdom to U.S.A.
Destination, rates & speeds

7.

Published by Wiley John + Sons (2010)
ISBN 10: 1405182350 ISBN 13: 9781405182355
New Hardcover Quantity Available: 1
Seller:
Rating
[?]

Book Description Wiley John + Sons, 2010. Condition: New. Seller Inventory # L9781405182355

More information about this seller | Contact this seller

Buy New
110.82
Convert currency

Add to Basket

Shipping: 2.69
From Germany to U.S.A.
Destination, rates & speeds

8.

Stefan Faderl
Published by Wiley John & Sons Nov 2010 (2010)
ISBN 10: 1405182350 ISBN 13: 9781405182355
New Quantity Available: 1
Seller:
Rheinberg-Buch
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description Wiley John & Sons Nov 2010, 2010. Buch. Condition: Neu. Neuware - Edited by experts from one of the world's largest leukemia centers, this book provides information on the biology of the variety of leukemic disorders, up-to-date diagnostic testing and many new developments in therapy. Chapters covering new treatments present an outlook for the future and explain the rationale for ongoing clinical trials.Topics include: Targeted therapy, e.g. tyrosine kinase inhibitors (Flt3, Aurora kinase inhibitors, kit inhibitors, BCR-ABL inhibitors) Ras inhibitors Epigenetic therapy (hypomethylaters and histone deacetylase inhibitors) Lenalidomide analogs New chemotherapy drugs, e.g. clofarabine, cloretazine, sapacitabine, forodesine Combinations of chemotherapy with kinase inhibitors (e.g. ALL induction protocols in combination with dasatinib or imatinib) New monoclonal antibodies (lumiliximab, humaxCD20, anti-CD40) Thrombopoietic agents Leukemias: Principles and Practice of Therapy Includes practical information to guide you in challenging situations, such as treatment of elderly patients, pregnancy, relapsed and refractory disease Incorporates chapters on supportive care and pharmacologic information about the most frequently used drugs in this area 446 pp. Englisch. Seller Inventory # 9781405182355

More information about this seller | Contact this seller

Buy New
110.82
Convert currency

Add to Basket

Shipping: 15.42
From Germany to U.S.A.
Destination, rates & speeds

9.

Stefan Faderl
Published by Wiley John & Sons Nov 2010 (2010)
ISBN 10: 1405182350 ISBN 13: 9781405182355
New Quantity Available: 1
Seller:
BuchWeltWeit Inh. Ludwig Meier e.K.
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description Wiley John & Sons Nov 2010, 2010. Buch. Condition: Neu. Neuware - Edited by experts from one of the world's largest leukemia centers, this book provides information on the biology of the variety of leukemic disorders, up-to-date diagnostic testing and many new developments in therapy. Chapters covering new treatments present an outlook for the future and explain the rationale for ongoing clinical trials.Topics include: Targeted therapy, e.g. tyrosine kinase inhibitors (Flt3, Aurora kinase inhibitors, kit inhibitors, BCR-ABL inhibitors) Ras inhibitors Epigenetic therapy (hypomethylaters and histone deacetylase inhibitors) Lenalidomide analogs New chemotherapy drugs, e.g. clofarabine, cloretazine, sapacitabine, forodesine Combinations of chemotherapy with kinase inhibitors (e.g. ALL induction protocols in combination with dasatinib or imatinib) New monoclonal antibodies (lumiliximab, humaxCD20, anti-CD40) Thrombopoietic agents Leukemias: Principles and Practice of Therapy Includes practical information to guide you in challenging situations, such as treatment of elderly patients, pregnancy, relapsed and refractory disease Incorporates chapters on supportive care and pharmacologic information about the most frequently used drugs in this area 446 pp. Englisch. Seller Inventory # 9781405182355

More information about this seller | Contact this seller

Buy New
110.82
Convert currency

Add to Basket

Shipping: 15.42
From Germany to U.S.A.
Destination, rates & speeds

10.

Faderl, Stefan (Editor)/ Kantarjian, Hagop (Editor)
Published by Blackwell Pub (2010)
ISBN 10: 1405182350 ISBN 13: 9781405182355
New Hardcover Quantity Available: 2
Seller:
Revaluation Books
(Exeter, United Kingdom)
Rating
[?]

Book Description Blackwell Pub, 2010. Hardcover. Condition: Brand New. 1st edition. 456 pages. 10.94x8.82x1.10 inches. In Stock. Seller Inventory # __1405182350

More information about this seller | Contact this seller

Buy New
123.73
Convert currency

Add to Basket

Shipping: 7.50
From United Kingdom to U.S.A.
Destination, rates & speeds

There are more copies of this book

View all search results for this book